AND

INFERGEN (interferon alfacon-1)

Profile

Contact Information

Currently Enrolling Trials

    Show More

    General Information

    A launch has taken place in the U.S. of Amgen's consensus interferon (interferon alfacon-1, INFERGEN) for the treatment of chronic hepatitis C virus infection.

    Approval Date: 1997-10-01
    Company Name: Amgen
    Back to Listings

    Upcoming Events

    Featured Products

    Featured Stories

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here